JP Jenkins Ltd
13th Nov 2024 ERS:JPJ
Eresos Holdings PLC ("Eresos" or "the Company") Shares soon to be trading on JP Jenkins
London, UK, 13th Nov 2024 – Eresos Holdings PLC (ERS:JPJ), today announces its shares are soon to be admitted to trade on JP Jenkins share dealing platform. The Company’s registered address is 85 Great Portland Street, London, United Kingdom, W1W 7LT and company number is 14747069.
Eresos is a company that makes CBD-infused products for health and wellbeing, including cosmetics, skincare, and nutraceuticals. The proposed plan is to go live for trading on the 2nd Dec 2024.
JP Jenkins provides a share trading venue for unlisted or unquoted assets in companies, enabling shareholders and prospective investors to buy and sell equity on a matched bargain basis. JP Jenkins is a trading name of InfinitX Limited and Appointed Representative of Prosper Capital LLP (FRN453007).
The indicative pricing for the ordinary shares as well as the transaction history, will be available on the JP Jenkins website at https://jpjenkins.com/company/eresos-holdings-plc/).
For further information, please contact:
ENDS
Dissemination of a CORPORATE NEWS, transmitted by EQS Group. |
2029165 13-Nov-2024
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.